Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001593968-24-000192

President and CEO acquired 317,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chang David D · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-25 Grant or award : show line 1 in the form +317,800 4,513,203 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-25 Grant or award : show line 2 in the form Stock Option (Right to buy) +1,123,535 1,123,535 D
Loading xslF345X05/primary_01.xml…